FDA Inspection
Hain-Celestial Canada, ULCHain-Celestial Canada, ULC – FDA Inspection, Sep 17, 2026
Record Details
This FDA Inspection record concerns Hain-Celestial Canada, ULC, with an inspection on September 17, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 979545d5-321a-40cf-8c5f-66e167046aad
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1336134
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hain-Celestial Canada, ULC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 21, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2012 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
Other documents for Hain-Celestial Canada, ULC
- FDA Inspection 1178470 - 2022-07-21
- FDA Inspection 960696 - 2016-02-18
- FDA Inspection 769330 - 2012-02-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.